With reference to Section 30 of the Danish Capital Markets Act, Ambu A/S hereby announces that on 9 September 2026, Ambu A/S has received three separate major shareholder notifications regarding voting rights attached to A-shares in Ambu A/S from:
The three major shareholder announcements are published as appendices to this company announcement.
Company announcement no. 18 2025/26.
Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,200+ Ambu team members are committed to delivering above and beyond.